Recombinant MLANA antibody
-
- Target See all MLANA Antibodies
- MLANA (Melan A (MLANA))
- Antibody Type
- Recombinant Antibody
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This MLANA antibody is un-conjugated
-
Application
- Immunohistochemistry (IHC)
- Immunogen
- Recombinant full-length hMART-1 protein
- Clone
- MSVA-901M-
- Isotype
- IgG
- Top Product
- Discover our top product MLANA Primary Antibody
-
-
- Application Notes
- IHC 1:50-1:100
- Comment
-
Positive Control: Skin: Virtually all melanocytes should show a strong Melan A+ immunostaining including a weak to moderate staining in melanocytic dendrites. Adrenal gland: An at least moderate Melan A+ immunostaining should be seen in adrenocortical cells.
Negative Control: Kidney: Melan A immunostaining should be absent in all cells. Adrenal gland: Melan A+ immunostaining should be absent in all medullary cells.
- Protocol
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:75 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
- Target
- MLANA (Melan A (MLANA))
- Alternative Name
- Melan A (MLANA Products)
- Synonyms
- A930034P04Rik antibody, Mart1 antibody, MART-1 antibody, MART1 antibody, melan-A antibody, Mlana antibody, MLANA antibody
- Background
- Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA,Melan A antibody validated for immunohistochemistry on 76 different Normal Tissues
- UniProt
- Q16655
-